1 min read

Connect with Veristat at the World Orphan Drug Congress 2017

 LinkedIn Image_World Orphan Drug Congress.png

Join Veristat and over 1000 big pharma, biotech, payers, and patient advocate groups at the World Orphan Drug Congress 2017


Topics will include the following:

  • Future of Orphan Drugs
  • Pricing & Reimbursement
  • Approval & Access
  • Gene Therapy
  • Scientific Innovation
  • Biosimilars

Why Veristat is Attending

Veristat is passionate about helping clients accelerate their rare disease therapies for unmet medical needs through the clinical development process. With over 350 million rare disease sufferers worldwide today, the urgency for more treatments is paramount.  Veristat is proud to have worked on over 235 rare disease treatments so far!

Nearly a third of our clinical trial work is for rare and ultra rare diseases!   Learn more about our rare disease experience. 


Schedule A Meeting      

To meet up with Veristat at this event or to connect with us at anytime, fill out the form on the right side of this page.  If you are attending the World Orphan Drug Congress 2017, you can request to connect with Eric Monroe or Kate Bentley through the conference partnering system.  

We look forward to connecting with you soon!

Share This Event:


1 min read

TOPRA Symposium 2024

Meet Veristat at the TOPRA Symposium 2024 from 30 September - 2 October in Rotterdam, the Netherlands 

The Veristat...

1 min read

World Orphan Drug Congress EUROPE  2024

Veristat is excited to announce its participation in this year's World Orphan Drug Congress Europe, held in Barcelona,...